Follow
MP Janssen
MP Janssen
Sanquin Blood Supply Foundation; Leiden University
Verified email at sanquin.nl
Title
Cited by
Cited by
Year
Aiming for a representative sample: Simulating random versus purposive strategies for hospital selection
LR van Hoeven, MP Janssen, KCB Roes, H Koffijberg
BMC medical research methodology 15 (1), 90, 2015
1382015
The PROTON study: profiles of blood product transfusion recipients in the Netherlands
BA Borkent‐Raven, MP Janssen, CL Van Der Poel, WP Schaasberg, ...
Vox sanguinis 99 (1), 54-64, 2010
1312010
Demographic changes and predicting blood supply and demand in the Netherlands
BA Borkent‐Raven, MP Janssen, CL Van Der Poel
Transfusion 50 (11), 2455-2460, 2010
772010
Two decades of risk factors and transfusion‐transmissible infections in Dutch blood donors
E Slot, MP Janssen, T Marijt‐van der Kreek, HL Zaaijer, TJ van de Laar
Transfusion 56 (1), 203-214, 2016
662016
First results of a ferritin‐based blood donor deferral policy in the Netherlands
M Vinkenoog, K van den Hurk, M van Kraaij, M van Leeuwen, ...
Transfusion 60 (8), 1785-1792, 2020
542020
Cost‐effectiveness of the screening of blood donations for hepatitis E virus in the Netherlands
AS Vos, MP Janssen, HL Zaaijer, BM Hogema
Transfusion 57 (2), 258-266, 2017
532017
Validity of assessing inhibitor development in haemophilia PUPs using registry data: the EUHASS project
K Fischer, D Lewandowski, H Marijke Van Den Berg, MP Janssen
Haemophilia 18 (3), e241-e246, 2012
462012
Cost‐effectiveness of additional blood screening tests in the Netherlands
BA Borkent‐Raven, MP Janssen, CL van der Poel, GJ Bonsel, ...
Transfusion 52 (3), 478-488, 2012
442012
A modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia A
K Fischer, ME Pouw, D Lewandowski, MP Janssen, HM van den Berg, ...
Haematologica 96 (5), 738-743, 2011
442011
Costs and benefits of bacterial culturing and pathogen reduction in the Netherlands
MP Janssen, CL Van Der Poel, E Buskens, L Bonneux, GJ Bonsel, ...
Transfusion 46 (6), 956-965, 2006
442006
Costs And Benefits Of Bacterial Culturing And Pathogen Reduction In The Netherlands
MP Janssen, CL van der Poel
Transfusion 45, 201A, 2005
442005
Modeling the transmission risk of emerging infectious diseases through blood transfusion
W Oei, MP Janssen, CL Poel, JE Steenbergen, S Rehmet, ...
Transfusion 53 (7), 1421-1428, 2013
432013
Carotid stenting versus carotid endarterectomy: evidence basis and cost implications
MP Janssen, GJ de Borst, WPTM Mali, LJ Kappelle, FL Moll, ...
European Journal of Vascular and Endovascular Surgery 36 (3), 258-264, 2008
402008
Cost-effectiveness of targeted screening for hepatitis C in The Netherlands
CW Helsper, BA Borkent-Raven, NJ De Wit, GA Van Essen, MJM Bonten, ...
Epidemiology and infection 140 (01), 58-69, 2012
382012
COST-EFFECTIVENESS OF TARGETED SCREENING FOR HEPATITIS C IN THE NETHERLANDS
CW Helsper, BA Borkent-Raven, NJ de Wit, GA van Essen, M Bonten, ...
VALUE IN HEALTH 12 (7), A429-A429, 2009
382009
Survival after transfusion in the Netherlands
BA Borkent‐Raven, MP Janssen, CL Van der Poel, WP Schaasberg, ...
Vox sanguinis 100 (2), 196-203, 2011
362011
Viral safety of human plasma–derived medicinal products: Impact of regulation requirements
KJ Velthove, J Over, K Abbink, MP Janssen
Transfusion medicine reviews 27 (3), 179-183, 2013
342013
Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and …
D Domanović, I Ushiro-Lumb, V Compernolle, S Brusin, M Funk, P Gallian, ...
Blood transfusion 17 (6), 433, 2019
332019
Cost‐effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands
BA Borkent‐Raven, MP Janssen, CL Van Der Poel, GA De Wit, GJ Bonsel, ...
Transfusion 49 (2), 311-319, 2009
332009
Direct costs of transfusion reactions–an expert judgement approach
MP Janssen, AJW Van Tilborgh, KMK De Vooght, AG Bokhorst, ...
Vox Sanguinis 113 (2), 143-151, 2018
312018
The system can't perform the operation now. Try again later.
Articles 1–20